688302 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Hinova Pharmaceuticals, Inc. engages in the research and development of pharmaceutical products. It offers castration-resistant prostate cancer treatment and anti-gout and hyperuricemia drugs. The company was founded by Yuan Wei Chen and Xing Hai Li on February 5, 2013 and is headquartered in Chengdu, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
688302 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company